0
There are 24 products.
Active filters
Category: Injectable Substances (GLP-1 Receptor Agonist, weight-loss medication)
Active Ingredient: Semaglutide
Packaging: Vial containing 4 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 7 days
Dosage: Most commonly 0.5 to 1 mg weekly (from 0.25 to 1 mg weekly)
Category: Injectable compounds (GLP-1 and GIP receptor agonist, medication for weight loss support)
Active ingredient: Tirzepatide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 5 days
Dosage: Most commonly 2.5 to 15 mg weekly (typically starting at 2.5 mg per week with gradual dose escalation based on tolerance)
Category: Synthetic peptide (GHRP)
Active ingredient: Ipamorelin
Packaging: 2 mg/vial
Manufacturer: General Pharmaceuticals
Half-life: approx. 2 hours
Abused dose: 100 to 300 mcg daily
Category: Injectable Compounds (Peptide Hormone)
Active Ingredient: IGF-1 LR3
Packaging: Vial containing 1 mg
Manufacturer: General Pharmaceuticals
Half-Life: Estimated at 2-3 hours
Category: Injectable compounds
Active ingredient: Human chorionic gonadotropin (HCG)
Packaging: 1 ampoule / 5000 IU
Manufacturer: General Pharmaceuticals
Half-life: 24 to 36 hours
Abused dose: 500 to 1500 IU once every 3 to 5 days
Category: synthetic peptide (GHRP)
Active substance: Growth Hormone Releasing Peptide-6 (increase in growth hormone and IGF-1 levels, improved sleep, fat reduction)
Packaging: 10 mg/vial
Manufacturer: General Pharmaceuticals
Half-life: approx. 0.5 to 1 hour
Abused dose: 100 to 300 mcg daily
Category: synthetic peptide (GHRP)
Active substance: Growth Hormone Releasing Peptide-2 (increase in growth hormone and IGF-1 levels, improved sleep, fat reduction)
Packaging: 10 mg/vial
Manufacturer: General Pharmaceuticals
Half-life: approx. 0.5 to 1 hour
Abused dose: 100 to 300 mcg daily
Category: synthetic peptide (pentadecapeptide)
Active substance: Body Protection Compound-157 (accelerates healing of tendons, ligaments, skin, muscles, intestines after injury; reduces inflammation)
Packaging: 5 mg/vial
Manufacturer: General Pharmaceuticals
Half-life: 4 to 6 hours
Abused dose: 200 to 500 mcg once or twice daily
Category: synthetic peptide (GHRP)
Active substance: Growth Hormone Releasing Peptide-2 (increase in growth hormone and IGF-1 levels, improved sleep, fat reduction)
Packaging: 10 mg/vial
Half-life: approx. 0.5 to 1 hour
Abused dose: 100 to 300 mcg daily
Category: synthetic peptide (GHRP)
Active substance: Growth Hormone Releasing Peptide-6 (increase in growth hormone and IGF-1 levels, improved sleep, fat reduction)
Packaging: 10 mg/vial
Half-life: approx. 0.5 to 1 hour
Abused dose: 100 to 300 mcg daily
Category: Injectable compounds (GLP-1, GIP, and glucagon receptor agonist; experimental weight loss medication)
Active ingredient: Retatrutide
Packaging: Vial containing 10 mg
Half-life: approximately 5–7 days
Dosage: Most commonly 2.5 to 12 mg weekly (typically titrated gradually based on tolerance)
Category: Injectable compounds (GLP-1 and GIP receptor agonist, medication for weight loss support)
Active ingredient: Tirzepatide
Packaging: Vial containing 10 mg
Half-life: approximately 5 days
Dosage: Most commonly 2.5 to 15 mg weekly (typically starting at 2.5 mg per week with gradual dose escalation based on tolerance)